Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.
about
Ion Channels in the HeartKATP channels and cardiovascular disease: suddenly a syndromeSoluble epoxide hydrolase inhibitors and heart failureSoluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophyAngiotensin II and tumour necrosis factor alpha as mediators of ATP-dependent potassium channel remodelling in post-infarction heart failureDifferent localization of ATP sensitive K+ channel subunits in rat testisCardiomyocyte sulfonylurea receptor 2-KATP channel mediates cardioprotection and ST segment elevation.Cardioprotective repair through stem cell-based cardiopoiesis.Regenerative Therapy Prevents Heart Failure Progression in Dyssynchronous Nonischemic Narrow QRS CardiomyopathyStem cell transplant into preimplantation embryo yields myocardial infarction-resistant adult phenotype.ATP-sensitive K+ channel knockout induces cardiac proteome remodeling predictive of heart disease susceptibility.Disruption of sarcolemmal ATP-sensitive potassium channel activity impairs the cardiac response to systolic overload.Human K(ATP) channelopathies: diseases of metabolic homeostasis.The FoxO family in cardiac function and dysfunction.Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction.Mutational analysis of KCNJ11 in Chinese elderly essential hypertensive patientsMechanical effects on KATP channel gating in rat ventricular myocytes.K(ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy.Exercise-induced expression of cardiac ATP-sensitive potassium channels promotes action potential shortening and energy conservation.Muscle KATP channels: recent insights to energy sensing and myoprotectionATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.ATP-Sensitive Potassium Channel Currents in Eccentrically Hypertrophied Cardiac Myocytes of Volume-Overloaded Rats.Advances in cardiac ATP-sensitive K+ channelopathies from molecules to populations.Fatty acid synthase modulates homeostatic responses to myocardial stress.Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistulaReduction in number of sarcolemmal KATP channels slows cardiac action potential duration shortening under hypoxia.Mice expressing a human K(ATP) channel mutation have altered channel ATP sensitivity but no cardiac abnormalities.Loss of ATP-Sensitive Potassium Channel Surface Expression in Heart Failure Underlies Dysregulation of Action Potential Duration and Myocardial Vulnerability to InjurySpontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice.Cardiac specific ATP-sensitive K+ channel (KATP) overexpression results in embryonic lethalityIschemia reperfusion injury, KATP channels, and exercise-induced cardioprotection against apoptosisCardiopoietic programming of embryonic stem cells for tumor-free heart repairKATP Channels in the Cardiovascular System.Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise.ATP-sensitive potassium channels: metabolic sensing and cardioprotection.K(ATP) channel pharmacogenomics: from bench to bedside.K(ATP) channel polymorphism is associated with left ventricular size in hypertensive individuals: a large-scale community-based study.Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.Targeted disruption of K(ATP) channels aggravates cardiac toxicity in cocaine abuseKATP channel Kir6.2 E23K variant overrepresented in human heart failure is associated with impaired exercise stress response.
P2860
Q26829681-2FFD4EB3-54EC-4218-BFD6-9E4B9BE1411BQ27013265-4FB5A5A1-F5E5-47A9-8C4D-3B6F427D2E1AQ28383423-EAD0A2B1-C31E-4597-AA37-0AC1115FA9B1Q28387081-1A7E125B-EC2D-4D43-9C5D-5FA20FEA7051Q28573667-51980ABA-5D6A-4B33-9783-6D3229C779C3Q29144186-D2C77BFE-689A-4952-9765-A00E45F42D4BQ29347291-156FA247-F04C-44B5-B44C-697A08C0E9A1Q30362960-CE25E1EC-6C2B-4781-984F-F8C195076409Q30401047-A61698BD-78B2-4CF7-A3C1-5E9C4B8FCA58Q33568190-67711AD3-5EC9-4BB8-A235-136D2CDE5866Q33638630-B688C627-C812-4DD7-BCBF-791205428A89Q33879972-DD6298EA-03E8-4119-801F-EA4187DBF81FQ33906965-A12148BB-5CBE-4F6B-8D08-789F5C157773Q34013124-4958F210-13A0-4320-8275-65C97A5CA097Q34338022-FD6CEA7B-9A96-419D-B889-24A7595B4CD5Q34390649-24C09296-0307-4249-A990-5F01008909E8Q34730257-DAA46C43-377F-4A37-807D-52BF1FE99BB1Q34808521-D0241ACE-914C-497C-B390-3D40FCB4C3AAQ35011954-1E860735-23D4-4706-BF6D-E6C5266D3F0DQ35076166-7E7EB377-FAAB-4E31-895B-60A5ACE1F7A8Q35087287-BB74F4E6-F817-4485-9B12-9D8E0E5C7F3FQ35159504-5D588219-A0F8-4839-9AD8-93224E9E1ABCQ35171519-8A076ADE-E1DD-47F8-95F1-3A60C34D80A3Q35183031-EB4D98CF-C7C5-4709-87CA-FD891718BB4DQ35326099-C3F75E17-7611-449B-9A64-420758B1E75AQ35592742-98A3253B-320B-4865-901B-40AC7AB0EFE7Q35809965-B9A7BE34-2B1B-4EA7-AFC8-0AD34944F1CAQ35952932-520E825A-F570-4698-AD09-E8022C190C4FQ36012386-37C53677-E9C6-4C2C-8FE9-BDDB48508A73Q36176733-4F0E469C-1F0F-4E27-A376-ECB55A7AD27FQ36184567-C49078EC-FF32-4555-9717-46885158407EQ36229704-3C1F1D9C-B013-45A3-BEFE-565A407F7DF4Q36422478-75DE8375-0F47-4407-B186-B29FF1021010Q36843601-1B226862-07F2-4054-BBE5-DB642067CFD7Q36886725-D2B23150-EB9B-44E9-BBB4-EB71A54265A4Q36980284-D326DA92-5576-4988-B12A-C34923BE4288Q36984053-A3E01BCE-4E8D-4EED-9D88-4D353C2EE13BQ36996311-2C631145-E7FF-48E2-ADF9-1E6A9B62E4F5Q37105578-CC4E4011-3036-4188-BC74-DBE600D1CE3CQ37167224-4890BA9C-FB55-4836-BA97-CD582FCEF7FD
P2860
Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Protection conferred by myocar ...... in KCNJ11 Kir6.2-null mutant.
@en
Protection conferred by myocar ...... in KCNJ11 Kir6.2-null mutant.
@nl
type
label
Protection conferred by myocar ...... in KCNJ11 Kir6.2-null mutant.
@en
Protection conferred by myocar ...... in KCNJ11 Kir6.2-null mutant.
@nl
prefLabel
Protection conferred by myocar ...... in KCNJ11 Kir6.2-null mutant.
@en
Protection conferred by myocar ...... in KCNJ11 Kir6.2-null mutant.
@nl
P2093
P2860
P1476
Protection conferred by myocar ...... in KCNJ11 Kir6.2-null mutant.
@en
P2093
Andre Terzic
Atta Behfar
Garvan C Kane
Randolph S Faustino
Roy B Dyer
Satsuki Yamada
Susumu Seino
Takashi Miki
Xiao-Ke Liu
P2860
P304
P356
10.1113/JPHYSIOL.2006.119511
P407
P577
2006-10-12T00:00:00Z